The Meyer Children Hospital is a pediatric hospital located in Florence, Italy. The hospital is an official member of the European Network of Health Promoting Hospitals of the World Health Organization ...

During the past decade, AOU Anna Meyer - Clinica di Neurologia Pediatrica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AOU Anna Meyer - Clinica di Neurologia Pediatrica" are "Dravet Syndrome" (1 trials), "Lennox Gastaut Syndrome" (1 trials) and "Spasms, Infantile" (1 trials). Many other conditions were trialed in "AOU Anna Meyer - Clinica di Neurologia Pediatrica" in a lesser frequency.

Most popular intervention types in "AOU Anna Meyer - Clinica di Neurologia Pediatrica" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AMZ002 injectable solution, 0.5mg/mL" (1 trials), "Matching Placebo" (1 trials), "Vigabatrin, oral" (1 trials), "ZX008 (Fenfluramine Hydrochloride)" (1 trials) and "ZX008 0.2 or 0.8 mg/kg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "AOU Anna Meyer - Clinica di Neurologia Pediatrica" are 3 trials for "All" genders.

Currently, there are NaN active trials in "AOU Anna Meyer - Clinica di Neurologia Pediatrica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AOU Anna Meyer - Clinica di Neurologia Pediatrica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AOU Anna Meyer - Clinica di Neurologia Pediatrica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".